January’s top news stories
Lilly to acquire Dermira for approximately $1.1bn Eli Lilly and Company (Lilly) signed a definitive agreement to acquire biopharmaceutical firm…
Round-up
-
-
November’s top news stories
Novartis to buy The Medicines Company for $9.7bn Novartis signed a definitive agreement to acquire US-based The Medicines Company for…
-
October’s top news stories
UCB to acquire Ra Pharmaceuticals in $2.1bn deal Belgian biopharmaceutical firm UCB signed a merger agreement to acquire US-based Ra…
-
August’s top news stories
Bayer agrees to acquire biotech BlueRock for $1bn German multinational pharmaceutical company Bayer signed an agreement to acquire US-based biotechnology…
-
July’s top news stories
Zirabev gets FDA approval to treat five types of cancer Pfizer secured US Food and Drug Administration (FDA) approval for…
-
May’s top news stories
Takeda to divest dry eye drug to Novartis in $5.3bn deal Takeda Pharmaceutical signed an agreement to sell its Xiidra…
-
April’s top news stories
Novartis to buy IFM Tre for up to $1.57bn Novartis agreed to acquire anti-inflammatory group IFM Tre, a subsidiary of…
-
February’s top news stories
Top pharma executives testify before US Senate over high prices Top executives from seven major pharmaceutical companies have appeared before the…
-
January’s top news stories
BMS acquires Celgene for an equity value of $74bn Bristol-Myers Squibb (BMS) has entered into a definitive merger agreement to…
-
M&As this week: Strides Pharma Science, Lambda Therapeutic Research, NextPharma
Strides Pharma Science’s step-down subsidiary Strides Pharma has made an arrangement to acquire Vensun Pharmaceuticals for $18m. Strides has agreed…